
While Procter & Gamble has notably underperformed the Nasdaq Composite recently, analysts remain moderately optimistic about the stock’s prospects.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

While Procter & Gamble has notably underperformed the Nasdaq Composite recently, analysts remain moderately optimistic about the stock’s prospects.

Dividend yield is a tool I use that tells me much more than just the income an investment generates.

A $610,000 pension lump sum sounds like freedom, but the monthly check comes with a guarantee that a dividend portfolio simply cannot replicate. Before you sign anything, there are three numbers that expose which choice actually leaves you better off.

A seven-figure portfolio looks like security until federal taxes, Medicare surcharges, Social Security phase-ins, and inflation each take their share. What actually clears into your checking account from $1.55 million depends on decisions most retirees never see coming.

Chasing a 7% blended yield across a $1.75 million portfolio sounds straightforward until you realize that loading up on the highest payers quietly destroys the very income stream you built. Three buckets solve the problem in ways that a single fund simply cannot.

Three quarterly dividend payers from the S&P 500 can cover every calendar month without touching a single REIT or BDC, and one of them has sent shareholders a check every year since Woodrow Wilson was president.

The yield is just average, but patient investors are still being well rewarded.

Sticky inflation is quietly rewarding a specific group of stocks with decades of uninterrupted dividend growth, and Wall Street's top analysts say five of them are built to profit no matter how long rising prices persist.

Procter & Gamble (PG) is back in consumer headlines after fresh marketing pushes from Charmin and Swiffer, including the Charmin Forever Roll and Swiffer Hair Magnet, just ahead of the back to college shopping season. These product pushes arrive as Procter & Gamble’s share price edges to US$145.40, with a modest gain on a year-to-date basis but a decline in the 1-year total shareholder return. This suggests recent momentum has softened, even as long-term total shareholder returns remain...

A nest egg of $840,000 sits right at the crossroads where dividends and annuities each look surprisingly compelling, and where the wrong choice quietly costs you tens of thousands of dollars over a 20-year retirement.

Retiring at 65 on dividends sounds straightforward until you realize the number you need today at 55 depends entirely on which yield tier you trust with your financial future, and the wrong choice leaves you no runway to recover.

The yield you chase to replace a six-figure income determines not just how much capital you need, but whether that income holds up a decade from now or quietly erodes beneath you.
Treasuries now yield nearly 5%, raising the stakes for every dividend stock in a boomer portfolio. Five companies have raised their payouts through recessions, inflation spikes, and rate cycles, and the case for owning them lifetime has never required more scrutiny.

Chasing a fatter dividend yield can quietly destroy the very income stream you built it to replace. Before you commit a dollar, understand why the yield number that looks most attractive often signals the greatest danger to your principal.

Building $37,200 a year in dividend income is a math problem first, and the yield tier you choose changes the capital required by hundreds of thousands of dollars in ways most investors never calculate before picking their first stock.

The beauty group's repricing rests on a profit plan it controls, while the low end of its new sales guidance is no faster than the year just ended.
While speculation runs hot and patience gets punished, three Dividend Kings with unbroken raise streaks spanning decades just posted results that made long-term holders take notice, and two of them are sitting at rare discounts heading into September.

Perrigo makes private-label over-the-counter drugs, which sounds like a reliable business, but there are warning signs to consider before you buy it.

In recent weeks, Procter & Gamble’s Charmin and Swiffer brands rolled out new consumer products and campaigns, including the Charmin Forever Roll “Roommate Trials” initiative and the Swiffer Hair Magnet launch with hair expert Jen Atkin. These moves highlight how P&G continues to refresh mature household categories through marketing-led innovation aimed at everyday pain points in shared living and home cleaning. We’ll now examine how P&G’s focus on everyday product innovation, exemplified by...

CLX's GOJO deal boosts fiscal 2027 sales, but inflation, acquisition costs and margin pressure could limit underlying growth.

CLX's GOJO-led growth faces margin pressure, muted core demand and inflation risks, leaving investors focused on a durable recovery.

CLX's rebound faces margin pressure, muted underlying demand and weaker earnings revisions despite GOJO and ERP tailwinds.

CL raised its 2026 profit outlook after a Q2 earnings beat and 140-basis-point margin gain, while higher costs and North America remain risks.

CL enters the second half with better volumes, resilient margins and a higher earnings outlook, but rich valuation and U.S. weakness temper the upside.

Three Dividend Kings with 50-plus years of raises could pay you for decades.

The 3% dividend yield doesn't tell the whole story.

Walmart just flashed a consumer stress signal that income investors cannot afford to ignore, and two Dividend Kings with decades of unbroken payout growth may be the only safe harbor left for retirees watching their portfolio checks.

It's rare for any company to be able to remain in a position to dominate its markets. This one is a compelling exception.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.